Aisling Foley co-founded ExCulture in 2022, motivated by the potential of ExCulture’s novel bioprocess to not only have a positive impact on patient outcomes but also to contribute to a more future-proof supply chain for life-saving medicines. Her academic background focused on environmental and sustainable chemistry at University College Dublin (BSc), the University of Virginia (international exchange), and Leiden University (MSc). Aisling grew up on a farm in Ireland, and before undertaking the role of CEO at ExCulture, she gained experience through internships in Process Development and Commercialisation at MSD and in Project Management (Finance/HR) at AkzoNobel.